Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.
暂无分享,去创建一个
[1] A. M. Lefer,et al. Cytokines and growth factors in endothelial dysfunction , 1993, Critical care medicine.
[2] G. Zimmerman,et al. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils , 1991, The Journal of cell biology.
[3] A. Beaudet,et al. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. , 1991, The Journal of clinical investigation.
[4] R. McEver. GMP‐140: A receptor for neutrophils and monocytes on activated platelets and endothelium , 1991, Journal of cellular biochemistry.
[5] L. Lasky. Lectin cell adhesion molecules (LEC‐CAMs): A new family of cell adhesion proteins involved with inflammation , 1991, Journal of cellular biochemistry.
[6] A. M. Lefer,et al. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion , 1991, Critical care medicine.
[7] A. M. Lefer,et al. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. , 1990, The American journal of physiology.
[8] S. Albelda,et al. Integrins and other cell adhesion molecules , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] T. Carlos,et al. Membrane Proteins Involved in Phagocyte Adherence to Endothelium , 1990, Immunological reviews.
[10] A. M. Lefer,et al. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. , 1990, The American journal of physiology.
[11] S. Djurić,et al. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. , 1989, Prostaglandins.
[12] E. Ohlstein,et al. Rabbit Polymorphonuclear Neutrophils Elicit Endothelium-Dependent Contraction in Vascular Smooth Muscle , 1989, Circulation research.
[13] Yanagisawa Masashi,et al. Molecular biology and biochemistry of the endothelins. , 1989 .
[14] S. Moncada,et al. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[15] D. Stewart,et al. Free radicals inhibit endothelium-dependent dilation in the coronary resistance bed. , 1988, The American journal of physiology.
[16] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[17] L. Ignarro,et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Moncada,et al. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.
[19] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[20] L. Touqui,et al. Perspectives in platelet-activating factor research. , 1987, Pharmacological reviews.
[21] R. A. Coleman. Methods in prostanoid receptor classification , 1987 .
[22] M. Weisfeldt,et al. Direct measurement of free radical generation following reperfusion of ischemic myocardium , 1987 .
[23] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[24] F. Murad,et al. Cyclic guanosine monophosphate as a mediator of vasodilation. , 1986, The Journal of clinical investigation.
[25] A. Stewart,et al. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4 , 1986, British journal of pharmacology.
[26] D. Handley,et al. Platelet activating factor and inflammation in atherogenesis: Targets for drug development , 1986 .
[27] R. Cotran,et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.
[28] I. Clark,et al. Free radical‐induced pathology , 1985, Medicinal research reviews.
[29] A. M. Lefer,et al. Pathophysiological mechanisms of sudden death induced by platelet activating factor , 1984, British journal of pharmacology.
[30] L. Becker,et al. Dissimilar Effects of Prostacyclin, Prostaglandin E1, and Prostaglandin E2 on Myocardial Infarct Size after Coronary Occlusion in Conscious Dogs , 1981, Circulation research.
[31] R. Berne. The role of adenosine in the regulation of coronary blood flow. , 1980, Circulation research.
[32] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[33] A. M. Lefer,et al. Studies on the protective effect of prostacyclin in acute myocardial ischemia. , 1979, European journal of pharmacology.
[34] S Moncada,et al. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.
[35] J. Vane,et al. Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium. , 1978, Prostaglandins.
[36] A. M. Lefer,et al. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. , 1978, Science.
[37] O. V. Miller,et al. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). , 1977, Prostaglandins.
[38] J. Vane,et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.
[39] J. Vane. The release and fate of vaso‐active hormones in the circulation , 1969, British journal of pharmacology.
[40] T. Williams,et al. Leukotrienes and inflammation. , 1990, Pharmacology & therapeutics.
[41] J. Vane,et al. The Role of the Endothelium in Vascular Homeostasis , 1990 .
[42] L. Horwitz,et al. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. , 1987, The Journal of clinical investigation.
[43] Lefer Am. Physiologic and pathophysiologic role of cyclo-oxygenase metabolites of arachidonic acid in circulatory disease states. , 1987, Cardiovascular clinics.
[44] P. Braquet. GINKGOLIDES: POTENT PLATELET ACTIVATING FACTOR ANTAGONISTS ISOLATED FROM GINKGO BILOBA L.: CHEMISTRY, PHARMACOLOGY AND CLINICAL APPLICATIONS , 1987 .
[45] Lefer Am,et al. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart. , 1987 .